title: Dynamic optimization of hybridoma growth in a fed-batch bioreactor.
abstract: This study addressed the problem of maximizing cell mass and monoclonal antibody production from a fed-batch hybridoma cell culture. We hypothesized that inaccuracies in the process model limited the mathematical optimization. On the basis of shaker flask data, we established a simple phenomenological model with cell mass and lactate production as the controlled variables. We then formulated an optimal control algorithm, which calculated the process-model mismatch at each sampling time, updated the model parameters, and re-optimized the substrate concentrations dynamically throughout the time course of the batch. Manipulated variables were feed rates of glucose and glutamine. Dynamic parameter adjustment was done using a fuzzy logic technique, while a heuristic random optimizer (HRO) optimized the feed rates. The parameters selected for updating were specific growth rate and the yield coefficient of lactate from glucose. These were chosen by a sensitivity analysis. The cell mass produced using dynamic optimization was compared to the cell mass produced for an unoptimized case, and for a one-time optimization at the beginning of the batch. Substantial improvements in reactor productivity resulted from dynamic re-optimization and parameter adjustment. We demonstrated first that a single offline optimization of substrate concentration at the start of the batch significantly increased the yield of cell mass by 27% over an unoptimized fermentation. Periodic optimization online increased yield of cell mass per batch by 44% over the single offline optimization. Concomitantly, the yield of monoclonal antibody increased by 31% over the off-line optimization case. For batch and fed-batch processes, this appears to be a suitable arrangement to account for inaccuracies in process models. This suggests that implementation of advanced yet inexpensive techniques can improve performance of fed-batch reactors employed in hybridoma cell culture.
authors.affiliation: AspenTech, Incorporated, 9896 Bissonnet Street, Houston, Texas 77036, USA.
authors.forename: S
authors.initials: S
authors.lastname: Dhir
authors.forename: K J
authors.initials: KJ
authors.lastname: Morrow
authors.forename: R R
authors.initials: RR
authors.lastname: Rhinehart
authors.forename: T
authors.initials: T
authors.lastname: Wiesner
mesh_terms: D000911:Antibodies, Monoclonal / Q000378:metabolism; D019149:Bioreactors; D002455:Cell Division; D006801:Humans; D006825:Hybridomas / Q000166:cytology* / Q000378:metabolism; D008954:Models, Biological
chemical_list: D000911:Antibodies, Monoclonal